essence clinical research success blending development disease oriented strategy development therapeutics begins single institution pilot exploratory studies treatment important strategic approach diseases treated ultimately exploratory studies encouraging confirmatory explanatory studies phase follow disease oriented advances treatment colorectal cancer hoped come new developmental therapeutics chemotherapy radiation therapy biologic response modifier therapy developments chemotherapy involve steady stream new drugs entering clinical trial drug development program nci pharmaceutical industry drugs include new structures analogues structures known active tumor types category particular emphasis placed new anthracycline analogues doxorubicin analogues cisplatinum diammine dichloride recognizing importance colorectal cancer experimental models tumor given prominence prediction active drugs include transpantable rodent colon tumors human colon tumors grown nude mice subrenal capsule addition clonogenic assay human tumor stem cells active investigation hoped assay able help predict patients colorectal tumors respond given available drugs help predict selection new active drugs colorectal cancer examples new developments radiation oncology eventual impact large bowel cancer include NUMBER high linear energy transfer deliverence techniques neutrons heavy ions NUMBER radiation sensitizers misonidazole desmethylmisonidazole newer electronic affinic compounds NUMBER radiation protectors NUMBER new fractionation schedules addition hyperthermia evolving viable approach killing neoplastic cells conjunction therapy biologic response modifiers brm new exciting development cancer treatment materials hopefully modify hosts ability react neoplastic cells way therapeutic benefit conjunction therapies brms current interferons thymic hormones interferons demonstrated ability shrink clinically evident breast cancers lymphomas supplies permit studies bowel cancer great modality oriented ii iii pi mesons wr NUMBER x ray